Dr. Molina is a graduate of Stanford University and received his medical degree from Baylor College of Medicine in Houston, Texas. He completed an Internal Medicine residency at the University of Texas in San Antonio and conducted his fellowship in Hematology–Oncology at the Fred Hutchinson Cancer Research Center/University of Washington in Seattle.
In addition to traditional medical oncology therapy options, such as chemotherapy, Dr. Molina utilizes new cutting-edge treatment approaches like immune and targeted therapies, which look at cancers at the molecular level, allowing him to focus on treating these genetic mutations with more effectiveness and precision, with fewer side effects than traditional medical oncology treatments.